0.019818
0.000000
0.008482
-0.000000
0.040420
0.000000
0.000000
-0.000000
0.022828
0.00000
0.00000
0.00000
Huguenin-Dezot, N.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.00
113.17
90.00
50.460
24.740
47.650
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C4 H10 O3
106.120
DI(HYDROXYETHYL)ETHER
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
O4 P -3
94.971
PHOSPHATE ION
non-polymer
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C4 H10 N O6 P
199.099
n
PHOSPHOTHREONINE
PHOSPHONOTHREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat. Methods
1548-7105
14
729
736
10.1038/nmeth.4302
28553966
Biosynthesis and genetic encoding of phosphothreonine through parallel selection and deep sequencing.
2017
100
1
PIXEL
2017-03-04
DECTRIS PILATUS3 6M
SINGLE WAVELENGTH
M
x-ray
1
0.97199
1.0
ID23-1
ESRF
0.97199
SYNCHROTRON
ESRF BEAMLINE ID23-1
8656.811
Polyubiquitin-B
1
man
polymer
94.971
PHOSPHATE ION
1
syn
non-polymer
106.120
DI(HYDROXYETHYL)ETHER
1
syn
non-polymer
18.015
water
62
nat
water
no
yes
MQIFVKTLTGK(TPO)ITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Human
sample
1
76
UBB
9606
Homo sapiens
562
Escherichia coli
Biological sequence
1
1.58
22.12
VAPOR DIFFUSION, SITTING DROP
4.2
20% (v/v) ethanol, 20% (w/v) PEG-1000, 0.1M Phosphate-citrate pH 4.2
291.15
citation
pdbx_audit_support
repository
Initial release
Database references
Database references
Author supporting evidence
1
0
2017-05-31
1
1
2017-06-07
1
2
2017-07-12
1
3
2017-09-13
_citation.country
_citation.journal_volume
_citation.page_first
_citation.page_last
_pdbx_audit_support.funding_organization
United Kingdom
Medical Research Council (United Kingdom)
MC_U105181009
United Kingdom
Medical Research Council (United Kingdom)
MC_UP_A024_1008
N
PDBE
Y
PDBE
2017-05-04
REL
REL
PO4
PHOSPHATE ION
PEG
DI(HYDROXYETHYL)ETHER
HOH
water
PO4
1
2
PO4
PO4
101
A
PEG
1
3
PEG
PEG
102
A
HOH
74
4
HOH
HOH
201
A
HOH
36
4
HOH
HOH
202
A
HOH
66
4
HOH
HOH
203
A
HOH
54
4
HOH
HOH
204
A
HOH
23
4
HOH
HOH
205
A
HOH
47
4
HOH
HOH
206
A
HOH
33
4
HOH
HOH
207
A
HOH
40
4
HOH
HOH
208
A
HOH
2
4
HOH
HOH
209
A
HOH
28
4
HOH
HOH
210
A
HOH
29
4
HOH
HOH
211
A
HOH
67
4
HOH
HOH
212
A
HOH
56
4
HOH
HOH
213
A
HOH
57
4
HOH
HOH
214
A
HOH
69
4
HOH
HOH
215
A
HOH
70
4
HOH
HOH
216
A
HOH
59
4
HOH
HOH
217
A
HOH
20
4
HOH
HOH
218
A
HOH
10
4
HOH
HOH
219
A
HOH
9
4
HOH
HOH
220
A
HOH
21
4
HOH
HOH
221
A
HOH
7
4
HOH
HOH
222
A
HOH
64
4
HOH
HOH
223
A
HOH
25
4
HOH
HOH
224
A
HOH
46
4
HOH
HOH
225
A
HOH
6
4
HOH
HOH
226
A
HOH
1
4
HOH
HOH
227
A
HOH
14
4
HOH
HOH
228
A
HOH
4
4
HOH
HOH
229
A
HOH
31
4
HOH
HOH
230
A
HOH
39
4
HOH
HOH
231
A
HOH
12
4
HOH
HOH
232
A
HOH
11
4
HOH
HOH
233
A
HOH
8
4
HOH
HOH
234
A
HOH
15
4
HOH
HOH
235
A
HOH
72
4
HOH
HOH
236
A
HOH
24
4
HOH
HOH
237
A
HOH
27
4
HOH
HOH
238
A
HOH
35
4
HOH
HOH
239
A
HOH
34
4
HOH
HOH
240
A
HOH
22
4
HOH
HOH
241
A
HOH
17
4
HOH
HOH
242
A
HOH
19
4
HOH
HOH
243
A
HOH
5
4
HOH
HOH
244
A
HOH
37
4
HOH
HOH
245
A
HOH
32
4
HOH
HOH
246
A
HOH
42
4
HOH
HOH
247
A
HOH
51
4
HOH
HOH
248
A
HOH
55
4
HOH
HOH
249
A
HOH
13
4
HOH
HOH
250
A
HOH
58
4
HOH
HOH
251
A
HOH
3
4
HOH
HOH
252
A
HOH
73
4
HOH
HOH
253
A
HOH
43
4
HOH
HOH
254
A
HOH
26
4
HOH
HOH
255
A
HOH
41
4
HOH
HOH
256
A
HOH
65
4
HOH
HOH
257
A
HOH
53
4
HOH
HOH
258
A
HOH
68
4
HOH
HOH
259
A
HOH
18
4
HOH
HOH
260
A
HOH
16
4
HOH
HOH
261
A
HOH
60
4
HOH
HOH
262
A
MET
1
n
1
MET
1
A
GLN
2
n
2
GLN
2
A
ILE
3
n
3
ILE
3
A
PHE
4
n
4
PHE
4
A
VAL
5
n
5
VAL
5
A
LYS
6
n
6
LYS
6
A
THR
7
n
7
THR
7
A
LEU
8
n
8
LEU
8
A
THR
9
n
9
THR
9
A
GLY
10
n
10
GLY
10
A
LYS
11
n
11
LYS
11
A
TPO
12
n
12
TPO
12
A
ILE
13
n
13
ILE
13
A
THR
14
n
14
THR
14
A
LEU
15
n
15
LEU
15
A
GLU
16
n
16
GLU
16
A
VAL
17
n
17
VAL
17
A
GLU
18
n
18
GLU
18
A
PRO
19
n
19
PRO
19
A
SER
20
n
20
SER
20
A
ASP
21
n
21
ASP
21
A
THR
22
n
22
THR
22
A
ILE
23
n
23
ILE
23
A
GLU
24
n
24
GLU
24
A
ASN
25
n
25
ASN
25
A
VAL
26
n
26
VAL
26
A
LYS
27
n
27
LYS
27
A
ALA
28
n
28
ALA
28
A
LYS
29
n
29
LYS
29
A
ILE
30
n
30
ILE
30
A
GLN
31
n
31
GLN
31
A
ASP
32
n
32
ASP
32
A
LYS
33
n
33
LYS
33
A
GLU
34
n
34
GLU
34
A
GLY
35
n
35
GLY
35
A
ILE
36
n
36
ILE
36
A
PRO
37
n
37
PRO
37
A
PRO
38
n
38
PRO
38
A
ASP
39
n
39
ASP
39
A
GLN
40
n
40
GLN
40
A
GLN
41
n
41
GLN
41
A
ARG
42
n
42
ARG
42
A
LEU
43
n
43
LEU
43
A
ILE
44
n
44
ILE
44
A
PHE
45
n
45
PHE
45
A
ALA
46
n
46
ALA
46
A
GLY
47
n
47
GLY
47
A
LYS
48
n
48
LYS
48
A
GLN
49
n
49
GLN
49
A
LEU
50
n
50
LEU
50
A
GLU
51
n
51
GLU
51
A
ASP
52
n
52
ASP
52
A
GLY
53
n
53
GLY
53
A
ARG
54
n
54
ARG
54
A
THR
55
n
55
THR
55
A
LEU
56
n
56
LEU
56
A
SER
57
n
57
SER
57
A
ASP
58
n
58
ASP
58
A
TYR
59
n
59
TYR
59
A
ASN
60
n
60
ASN
60
A
ILE
61
n
61
ILE
61
A
GLN
62
n
62
GLN
62
A
LYS
63
n
63
LYS
63
A
GLU
64
n
64
GLU
64
A
SER
65
n
65
SER
65
A
THR
66
n
66
THR
66
A
LEU
67
n
67
LEU
67
A
HIS
68
n
68
HIS
68
A
LEU
69
n
69
LEU
69
A
VAL
70
n
70
VAL
70
A
LEU
71
n
71
LEU
71
A
ARG
72
n
72
ARG
72
A
LEU
73
n
73
LEU
73
A
ARG
74
n
74
ARG
74
A
GLY
75
n
75
GLY
75
A
GLY
76
n
76
GLY
76
A
author_and_software_defined_assembly
PISA
1
monomeric
none
290
-4
4730
A
TPO
12
modified residue
A
TPO
12
THR
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
ILE
13
A
O
ILE
13
A
N
VAL
5
A
N
VAL
5
A
N
PHE
4
A
N
PHE
4
A
O
LEU
67
A
O
LEU
67
A
O
VAL
70
A
O
VAL
70
A
N
ARG
42
A
N
ARG
42
A
N
PHE
45
A
N
PHE
45
A
O
LYS
48
A
O
LYS
48
1
A
CD
LYS
63
A
CD
LYS
63
1
Y
1
A
CE
LYS
63
A
CE
LYS
63
1
Y
1
A
NZ
LYS
63
A
NZ
LYS
63
1
Y
1
A
NH1
ARG
72
A
NH1
ARG
72
1
Y
1
A
A
O
O
HOH
HOH
230
256
1.62
1
A
A
O
O
HOH
HOH
208
218
1.83
1
A
A
O
O
HOH
HOH
208
254
1.91
1
A
A
O
O
HOH
HOH
238
256
2.08
1
15.94
2.30
111.70
127.64
A
A
A
CD
CE
NZ
LYS
LYS
LYS
6
6
6
A
A
A
N
1
-5.73
0.90
118.30
112.57
A
A
A
CB
CG
OD2
ASP
ASP
ASP
32
32
32
N
1
6.18
0.50
120.30
126.48
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
42
42
42
N
1
3.03
0.50
120.30
123.33
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
54
54
54
A
A
A
N
1
-3.35
0.50
120.30
116.95
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
54
54
54
A
A
A
N
1
4.40
0.50
120.30
124.70
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
72
72
72
N
1
10.55
1.70
111.00
121.55
A
A
A
CB
CG
CD1
LEU
LEU
LEU
73
73
73
N
1
A
A
CD
OE2
GLU
GLU
16
16
0.155
0.011
1.252
1.407
N
1
A
A
CD
CE
LYS
LYS
27
27
-0.167
0.025
1.508
1.341
N
1
A
A
C
O
PRO
PRO
37
37
0.126
0.020
1.228
1.354
N
1
A
A
CB
CG
ASP
ASP
39
39
-0.180
0.021
1.513
1.333
N
1
A
A
CB
OG
SER
SER
57
57
-0.099
0.013
1.418
1.319
B
B
N
1
A
A
O
O
HOH
HOH
213
213
0.89
1_555
2_556
1
A
A
O
O
HOH
HOH
209
225
1.03
1_555
3_455
1
A
A
O2P
OD2
TPO
ASP
12
52
1.73
B
1_555
1_545
1
A
A
O3
O
PO4
HOH
101
217
1.80
1_555
3_545
1
A
A
O
O
HOH
HOH
257
257
1.99
1_555
2_555
1
A
A
NZ
O
LYS
HOH
6
221
2.10
B
1_555
1_545
1
A
A
O
O
GLY
HOH
75
216
2.19
1_555
4_456
1
A
A
O
O
HOH
HOH
203
256
2.19
1_555
1_545
1
A
THR
9
-140.57
16.83
16.872
1.10
-0.00
-0.36
-0.84
-0.00
0.04
0.981
0.973
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
0.16653
0.12905
0.13092
1.07
43.81
1103
21851
4.8
95.13
1.234
0.027
RANDOM
1
THROUGHOUT
MOLECULAR REPLACEMENT
0.034
0.036
0.80
0.80
1.20
MAXIMUM LIKELIHOOD
MASK
1.07
43.81
62
676
12
0
602
0.037
0.019
780
0.003
0.020
766
3.261
2.035
1074
1.800
3.000
1804
7.429
5.000
108
30.112
25.758
33
15.250
15.000
158
14.835
15.000
5
0.190
0.200
125
0.013
0.021
882
0.010
0.020
132
3.504
1.252
381
3.314
1.248
380
4.889
1.885
492
4.887
1.896
493
4.442
1.629
399
4.437
1.628
399
4.990
2.297
577
19.515
17.945
823
19.486
17.500
811
7.268
3.000
1545
38.529
5.000
22
40.109
5.000
1568
0.303
0.262
1.098
84
1555
20
94.03
1.07
43.81
5NVG
22954
0.087
1
7.5
2.9
95.6
1.07
1.09
1
refinement
REFMAC
5.8.0158
model building
Coot
phasing
PHASER
data reduction
iMOSFLM
data scaling
Aimless
N
Polyubiquitin-B
Thr12 Phosphorylated Ubiquitin
1
N
N
2
N
N
3
N
N
4
N
N
A
THR
22
A
THR
22
HELX_P
A
GLY
35
A
GLY
35
1
AA1
14
A
PRO
37
A
PRO
37
HELX_P
A
ASP
39
A
ASP
39
5
AA2
3
A
LEU
56
A
LEU
56
HELX_P
A
ASN
60
A
ASN
60
5
AA3
5
covale
1.301
both
A
A
LYS
11
A
C
LYS
11
1_555
A
TPO
12
A
N
TPO
12
1_555
covale
1.311
both
B
A
LYS
11
A
C
LYS
11
1_555
A
TPO
12
A
N
TPO
12
1_555
covale
1.347
both
A
A
A
TPO
12
A
C
TPO
12
1_555
A
ILE
13
A
N
ILE
13
1_555
covale
1.340
both
B
B
A
TPO
12
A
C
TPO
12
1_555
A
ILE
13
A
N
ILE
13
1_555
SIGNALING PROTEIN
ubiquitin phosphoubiquitin phosphorylation phosphothreonine, signaling protein
UBB_HUMAN
UNP
1
1
P0CG47
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG
1
76
5NVG
1
76
P0CG47
A
1
1
76
5
anti-parallel
parallel
anti-parallel
anti-parallel
A
TPO
12
A
TPO
12
A
GLU
16
A
GLU
16
A
GLN
2
A
GLN
2
A
THR
7
A
THR
7
A
THR
66
A
THR
66
A
LEU
71
A
LEU
71
A
GLN
41
A
GLN
41
A
PHE
45
A
PHE
45
A
LYS
48
A
LYS
48
A
GLN
49
A
GLN
49
binding site for residue PO4 A 101
A
PO4
101
Software
8
binding site for residue PEG A 102
A
PEG
102
Software
8
A
LYS
11
A
LYS
11
8
3_555
A
ASP
39
A
ASP
39
8
3_545
A
PHE
45
A
PHE
45
8
1_555
A
LYS
48
A
LYS
48
8
1_555
A
TYR
59
A
TYR
59
8
1_555
A
ASN
60
A
ASN
60
8
1_555
A
HOH
207
D
HOH
8
1_555
A
HOH
217
D
HOH
8
3_545
A
PRO
19
A
PRO
19
8
1_555
A
SER
20
A
SER
20
8
1_555
A
SER
20
A
SER
20
8
2_555
A
THR
55
A
THR
55
8
1_555
A
THR
55
A
THR
55
8
2_555
A
SER
57
A
SER
57
8
1_555
A
ASP
58
A
ASP
58
8
2_555
A
HOH
210
D
HOH
8
2_555
5
C 1 2 1